|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
(Email: s_sano@cc.okayama-u.ac.jp).
| The first 20% of the full text of this article appears below. |
The right ventricle-pulmonary artery (RV-PA) shunt was first introduced by Norwood and colleagues [1] in 1981 as a first-stage palliation of hypoplastic left heart syndrome (HLHS) and was abandoned until 1998 when we started using this technique with the modification of a small nonvalved polytetrafluoroethylene (PTFE) graft [2]. Since then, many centers have adopted stage I palliation with an RV-PA shunt and reported significant improvement in stage I mortality and morbidity. In some centers, mortality in stage I palliation has dropped below 10% [3]. However, controversies still remain regarding the systemic-to-pulmonary shunt versus the RV-PA shunt on the long-term results of HLHS [4].
In this article, Januszewska and colleagues [
Related Article
Ann. Thorac. Surg. 2007 84: 1611-1617.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |